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Abstract
Introduction Claudins, membrane-associated tetraspanin
proteins, are normally associated with the tight junctions of
epithelial cells where they confer a variety of permeability
properties to the transepithelial barrier. One member of this
family, claudin 7, has been shown to be expressed in the human
mammary epithelium and some breast tumors. To set the stage
for functional experiments on this molecule, we examined the
developmental expression and localization of claudin 7 in the
murine mammary epithelium and in a selection of murine
mammary tumors.
Method We used real-time polymerase chain reaction, in situ
mRNA localization, and immunohistochemistry (IHC) to examine
the expression and localization of claudin 7. Frozen sections
were examined by digital confocal microscopy for colocalization
with the tight-junction protein ZO1.
Results Claudin 7 was expressed constitutively in the mammary
epithelium at all developmental stages, and the ratio of its mRNA
to that of keratin 19 was nearly constant through development.
By IHC, claudin 7 was located in the basolateral part of the cell
where it seemed to be localized to discrete vesicles. Scant
colocalization with the tight-junction scaffolding protein ZO1
was observed. Similar results were obtained from IHC of the
airway epithelium and some renal tubules; however, claudin 7
did partly colocalize with ZO1 in EPH4 cells, a normal murine
mammary cell line, and in the epididymis. The molecule was
localized in the cytoplasm of MMTV-neu and the transplantable
murine tumor cell lines TM4, TM10, and TM40A, in which its
ratio to cytokeratin was higher than in the normal mammary
epithelium.
Conclusion Claudin 7 is expressed constitutively in the
mammary epithelium at approximately equal levels throughout
development as well as in the murine tumors examined.
Although it is capable of localizing to tight junctions, in the
epithelia of mammary gland, airway, and kidney it is mostly or
entirely confined to punctate cytoplasmic structures, often near
the basolateral surfaces of the cells and possibly associated
with basolateral membranes. These observations suggest that
claudin 7 might be involved in vesicle trafficking to the
basolateral membrane, possibly stabilizing cytoplasmic vesicles
or participating in cell–matrix interactions.
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Introduction
The claudins comprise a large family of tetraspanin mem-
brane proteins thought to be the major barrier-forming pro-
teins of tight junctions, the cell–cell contacts at the apical
border of epithelial cells that control the paracellular move-
ment of solutes. These proteins are highly conserved, with
four transmembrane domains and two hydrophobic extra-
cellular loops; the latter are thought to mediate cell–cell
adhesion [1] and to confer specific paracellular permeabil-
ity properties on cell monolayers [2,3]. Claudin 7 shares the
general structural characteristics of the family, differing pri-
marily in its amino-terminal cytoplasmic tail [4]. The mole-
cule has been shown to be associated with epithelial cells
in the human breast [5], and its loss is associated with
some breast and head and neck malignancies [5,6]. It has
been shown to be expressed in parts of the renal tubule [7]
and the airway epithelium [8], where it is localized to the
basolateral aspects of the cells. Here we show that claudin
7 is constitutively present in the epithelium of the murine
mammary gland, again localized, not to tight junctions but
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to punctate structures at or near the basolateral surfaces of
the cells. It was present at all cell borders of several murine
mammary tumors. Nonetheless, the protein can localize to
tight junctions, as shown by its partial colocalization with
ZO1 in cultured mammary epithelial cells and epididymis,
suggesting a possible dual function depending on tissue
type.
Method
Animals and tissue preparation
CD-1 mice, purchased from Charles River Breeding Labo-
ratory (Wilmington, DE), were maintained in the USDA-
approved Animal Resource Center of the University of
Colorado Health Sciences Center. All procedures were
approved by the Institutional Animal Care and Use Commit-
tee. The fourth mammary glands of virgin female mice at 3,
6, and 12 weeks of age, of female mice during early gesta-
tion (5–7 days), mid-gestation (12 days) and late gestation
(18 days), at days 2 and 10 of lactation, and at days 21 and
29 of involution were collected after killing with a lethal
dose of pentobarbital. Liver, lung, and kidneys were
obtained from virgin female mice and epididymis from male
mice. The day on which vaginal plugs were observed was
counted as day one of pregnancy. Mice overexpressing the
Her2/neu oncogene [9] were obtained from Jackson Lab-
oratories, and mammary tumors were dissected and frozen
when they reached about 0.5 cm in diameter. The trans-
plantation tumor models TM4, TM10L, and TM40 are main-
tained in the Medina laboratory as described [10]. Tissues
were flash-frozen in liquid nitrogen in Tri-Zol reagent (Gibco
BRL, Life Technologies) for total RNA purification. For pro-
tein extractions, the tissue was washed twice in 1 ml of
phosphate-buffered saline (PBS) and then placed in 3 vol-
umes of 1% Nonidet P40 buffer (25 mM Hepes-NaOH, pH
7.4; 150 mM NaCl, 4 mM EDTA, 1% Nonidet P40) contain-
ing protease inhibitors (10 µg/µl leupeptin, 10 µg/µl apro-
tinin, 10 µM pepstatin A, 1 mM phenylmethylsulphonyl
fluoride, in dimethyl sulphoxide). For hybridizations and
immunohistochemistry of frozen tissue in situ, tissues were
placed in Tissue-Tek OCT 4583 Compound (Sakura, Tor-
rance, CA) and flash-frozen in isopentane and liquid nitro-
gen. All samples were stored at – 70°C until ready for use.
Characterization of an antibody against claudin 7
A rabbit antibody was custom-made against the carboxy-
terminal peptide of murine claudin 7, APRSYPKSNSS-
KEYV, by Zymed Laboratories (San Francisco, CA). This
affinity-purified antibody bound only a 23 kDa peptide by
western blotting, did not cross-react with claudin 1, its
closest congener, in claudin-1-transfected Cos cells or at
the apical border of the mammary epithelium where claudin
1 is present at junctional complexes, and stained only epi-
thelia where its mRNA has been demonstrated. Staining
was blocked by preincubation of the antibody with the pep-
tide. Cos cells transfected with full-length claudin 7 were
stained by this antibody but not by an antibody against
claudin 1.
Protocol for real-time polymerase chain reaction
For real-time reverse transcriptase polymerase chain reac-
tion, RNA was purified with the Qiagen system: 1 µg of
DNase-treated RNA was used for each reaction. Triplicate
tissue samples were assayed in duplicate with the ABI
Prism 7700 sequence detection system, with lung as the
positive control. Primer sequences were as follows: murine
claudin 7, forward 5' -CGAAGAAGGCCCGAATAGCT-3'
(338-337), reverse 5' -GCTACCAAGGCAGCAAGACC-
3' (407–388), probe5' -GCCACAATGAAAACAAT-
GCCTCCAGTCA-3' (359–386); murine cytokeratin 19,
forward 5' -TTTAAGACCATCGAGGAC-3', reverse 5' -
TCATACTGACTTCTCATCTCAC-3'.
Immunohistochemistry and digital confocal microscopy
Rat anti-mouse ZO1 antibody was obtained from Chemi-
con International Inc. (Temecula, CA). Tissue sections were
cut at 10 µm thickness from frozen blocks with a Damon/
IEC division minotome set at – 18 to -20°C. Sections were
collected onto Cell-Tak coated coverslips and were further
vapor-fixed with paraformaldehyde for 15 min. Sections
were never allowed to dry. PBS was added carefully so as
to not disrupt the sections. Tissue was permeabilized with
1% Triton X-100 for 15 min, rinsed well with PBS and
blocked with sterifiltered 10% normal donkey serum for 20
min. All antibody solutions were microfuged for 20 min
before use. The claudin antibody was diluted 1:1000. Pri-
mary incubations were for 1 hour at 21–22°C, followed by
extensive washes in PBS, generally six times for 5 min
each. Secondary antibodies were diluted in accordance
with the manufacturer's instructions, in PBS alone. The
host species of all secondary antibodies was donkey and
all secondary antibodies were cross-adsorbed against
mouse serum proteins. Antibodies used were conjugated
to fluorescein, CY3 or CY5. Secondary antibodies were
combined with 0.6 µg/ml 4,6-diamidino-2-phenylindole,
and incubated on the tissue for 1 hour. Coverslips were
rinsed briefly and permitted to soak overnight in PBS.
Images were collected with SlideBook software (Intelligent
Imaging Innovations, Inc., Denver, CO) on a Nikon Diaphot
TMD microscope equipped for fluorescence with a xenon
lamp and filter wheels (Sutter Instruments, Novato, CA), flu-
orescent filters (Chroma, Brattleboro, VT), cooled charge-
coupled device camera (Cooke, Tonawanda, NY) and step-
per motor (Intelligent Imaging Innovations, Inc., Denver,
CO). Multi-fluor images were merged, deconvolved, and
renormalized with SlideBook software.Available online http://breast-cancer-research.com/content/7/2/R248
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Results
Developmental expression of claudin 7 mRNA in the 
mammary gland
Figure 1a shows claudin 7 gene expression as a function of
developmental stage in the mouse mammary gland from the
virgin animal (non-pregnant non-lactating) through preg-
nancy (days P5, P12, and P18), lactation (days L2, L10,
and L19), and involution (days L22 and L29). Gene expres-
sion increased more than 1000-fold between the virgin and
early lactating gland, leveling out through lactation and
decreasing at late involution (day L29) with the loss of epi-
thelial cells. To determine whether expression of claudin 7
was a function of developmental stage or epithelial cell
number, we also examined the expression of keratin 19,
found only in luminal epithelial cells [11]. As can be seen,
claudin 7 expression parallels that of keratin 19. Further,
the ratio of claudin 7 to keratin 19 (Fig. 1a, dotted line) is
relatively constant through pregnancy and early lactation,
increasing only during later lactation when the expression
of keratin 19 mRNA decreases significantly.
At late involution, day L29, claudin 7 expression was lower
than that of keratin 19, for reasons that are not clear but
probably have to do with the types and characteristics of
epithelial cells present during late glandular remodeling.
Similar results were obtained from microarray analysis
(data not shown). In situ hybridization with 35S-labeled
RNA probes to claudin 7 showed that the mRNA was local-
ized to the epithelium in virgin, pregnant, and lactating ani-
mals (Fig. 1b). We conclude that, in the normal mammary
gland, claudin 7 is an epithelial cell marker expressed at
approximately constant levels through development. The
very large changes in expression levels during pregnancy
most probably reflect an increase in cell number as the
mammary epithelium expands from a system of sparse
ducts in the virgin gland, to a dense mass of lactating cells
in a gland in which the adipose tissue is largely obliterated.
Immunolocalization of claudin 7 in the mammary gland
We made and characterized an affinity-purified antibody
against the cytoplasmic tail of claudin 7 (see Methods) that
proved quite satisfactory for both western blots (Fig. 2a)
and immunohistochemistry on both frozen and paraffin sec-
tions. Given the well-known association of claudins with
tight junctions, we were surprised to find that claudin
stained the basolateral region of mammary cells in all
stages of development (Fig. 2b,c). A ductal structure sur-
rounded by adipose stroma is shown in the virgin; alveoli
from the pregnant and lactating glands are also shown (Fig.
2b). Staining was blocked when the antibody was preab-
sorbed with the claudin 7 peptide against which it was
made (Fig. 2b, lower right). As with the in situ analysis, stain
was observed only in luminal epithelial cells. Although there
seems to be some colocalization of claudin 7 with stain for
the tight-junction scaffolding protein ZO1 in the lower-
power images of Fig. 2b, at higher magnification (Fig. 2c)
claudin 7 was entirely localized to the basal and lateral cyto-
plasmic regions, where it often appeared punctate in
nature, particularly when it was not closely apposed to the
cell border. Stain was excluded from nuclei (blue) and
Figure 1
Developmental expression of claudin 7 mRNA in the murine mammary gland Developmental expression of claudin 7 mRNA in the murine mammary gland. (a) Real-time reverse transcriptase polymerase chain reaction measure-
ment of claudin 7 and keratin 19 from total mammary glands of non-pregnant non-lactating (NPNL) mice, mice at 5, 12, and 18 days of pregnancy 
(P5, P12, and P18), and mice at 2, 10, 19, 22, and 29 days post partum (L2, L10, L19, L22, and L29). By L29 the pups have weaned themselves, 
and mammary gland involution is nearly complete. Dotted line, ratio of claudin 7 RNA to keratin 19 at the same time points. Three mice analyzed at 
each time point. Error bars represent SEM. Where no bar is visible, the SEM falls within the symbol. Asterisks indicate points that differ significantly 
from values at L2, P < 0.05. (b) In situ hybridization of claudin 7 probes to sections from virgin, pregnant, and lactating mammary glands. Sections 
labeled A were hybridized to the anti-sense probe; the lower right-hand section labeled S is the sense control. Scale bar, 20 µm.Breast Cancer Research    Vol 7 No 2    Blackman et al.
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largely from tight junctions (green), as shown by the mini-
mal overlap between the green and red stain in Fig. 2c. It
seems likely that there is basolateral membrane staining in
this tissue, but the basal and lateral membranes of the
mammary epithelial cells are deeply infolded and mem-
brane localization cannot be assessed at the magnifica-
tions possible with the light microscope.
When immunohistochemistry is used in the characteriza-
tion of claudins, there is always a concern that the antibody
cross-reacts with another claudin species. We have found
claudins 1, 3, and 8 in the murine mammary epithelium (MC
Neville, unpublished data); however, claudin 7 stain shows
entirely different patterns from these claudins. As shown in
Fig. 2a, claudin 1 is localized at the position of the junc-
tional complexes; claudin 3 is present in epithelium from vir-
gin and pregnant glands, whereas claudin 8 is present only
during lactation. These experiments will be described in
detail elsewhere.
Claudin 7 localization in other cell types
Sukumar and colleagues [5] reported that claudin 7 was
localized to tight junctions of the human mammary carci-
noma cell line MCF-7 by using an antibody directed toward
the cytoplasmic tail of the human protein, which differs by
one amino acid from the mouse protein. We therefore
examined claudin 7 staining in the normal mouse mammary
cell line EPH4 [12,13]. Figure 3a shows the distribution of
claudin and ZO-1 in EPH4 cells. Claudin 7 distinctly colo-
calizes with ZO-1 with a slightly less compact distribution,
as shown by the zy image at the top of the figure as well as
the xy image just below. A scattering of cytoplasmic vesi-
cles containing claudin 7 can also be seen. This finding
suggests that claudin 7 is capable of localizing to tight junc-
tions, a conclusion supported by the distribution of claudin
7 in the epididymis (Fig. 3b), where claudin 7 colocalized
with ZO-1 at the apical borders of some cells but not oth-
ers. Punctate cytoplasmic stain for claudin 7 could also be
observed in some cells.
Claudin 7 mRNA was reported in lung and kidney, with liver
being negative [4]. We therefore examined these tissues
and found that claudin 7 was present in cells lining bronchi-
olar structures of the lung, where its distribution was mainly
cytoplasmic as observed previously [8] (Fig. 3c). However,
careful examination of a black-and-white image at the high-
est magnification in the luminal cells of this structure shows
some claudin 7 to be colocalized with ZO-1, suggesting
that it might also be associated with tight junctions in these
cells. There was no stain in the pulmonary alveoli. In the
renal cortex we found claudin 7 localized only to certain
segments, identified as connecting tubules and cortical
collecting ducts by Li and colleagues [7], where stain was
distinctly basolateral (Fig. 3d). Because our antibody was
different from that used by Li and colleagues, our finding
Figure 2
Claudin 7 immunohistochemistry in the mammary gland Claudin 7 immunohistochemistry in the mammary gland. (a) Western 
blot on 50 µg of protein from mammary gland at pregnancy days 7 and 
18 (P7 and P18) and lactation days 2 and 9 (L2 and L9). Because 
gene expression is 20-fold lower at P7, as can be seen from Fig. 1a, 
protein would not be expected to be visible at this exposure. Right-hand 
side: section of gland from virgin mouse stained with antibody (Zymed) 
to Claudin 1. (b) Lower-power views of epithelial structures from the 
developmental stages indicated with fluorescein isothiocyanate-labeled 
ZO-1 (green), Cy3-labeled claudin 7 (red), and 4,6-diamidino-2-phe-
nylindole-labeled nuclei (blue). Lu, lumen; adip, adipocyte. Lower right: 
anticlaudin antibody blocked with claudin 7 peptide. Scale bar, 30 µm. 
(c) High-power views of claudin 7 localization. The right-hand images 
show the merged views as in (b). The left-hand black-and-white images 
show only the claudin 7 stain, demonstrating clearly the punctate nature 
of the claudin 7 distribution near the basolateral membranes; claudin 7 
is excluded from both nuclei and tight junctions. Scale bar, 10 µm. 
Arrows in all figures point to FITC-stained ZO-1 (green).Available online http://breast-cancer-research.com/content/7/2/R248
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Figure 3
Immunolocalization of claudin 7 (Cy3, red) in cultured mammary epithelial cells, epididymis, lung, kidney, and liver Immunolocalization of claudin 7 (Cy3, red) in cultured mammary epithelial cells, epididymis, lung, kidney, and liver. ZO-1 is stained with fluorescein 
isothiocyanate to demonstrate location of the tight junctions. (a) Eph4 cells. Claudin 7 is found with a patchy distribution at the tight junctions with 
ZO1. Vesicular stain can also be seen in the cytoplasm. The inset at the top shows the z axis across the xy view of the section at the level of the 
arrow. The overlap of ZO1 and claudin indicates colocalization at the level of resolution of the light microscope. (b) Mouse epididymis. Claudin 7 
stain colocalizes with ZO-1 in most, but not all, tight junctions. Lu, lumen. Small arrowheads in this and subsequent panels denote the apical border 
of the epithelium. (c) Lung. The luminal cells of the bronchiole show heavy staining for claudin 7 in a punctate distribution at the basolateral surface 
of the cell; however, some claudin 7 colocalizes with ZO-1 (see black-and-white inset). (d) Kidney. Some of the tubules of the renal cortex stain as 
observed by Li and colleagues [7]. Claudin 7 shows a punctate distribution that is heaviest in the basal portion of the cells. (e) Liver. Tight junctions 
at the bile canaliculi are stained with ZO-1. However, no stain for claudin 7 is apparent. The magnification for each figure is indicated by the label (u, 
µm) above the scale bar.Breast Cancer Research    Vol 7 No 2    Blackman et al.
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confirms this localization. At high magnification the stain is
punctate, as in the mammary and airway epithelia. No spe-
cific claudin stain was observed in the liver (Fig. 3e). These
findings indicate that claudin 7 is capable of localizing to
tight junctions, as in cultured mammary epithelial cells and
epididymis; however, in mammary gland, airway, and kidney
it is mostly or entirely confined to punctate cytoplasmic
structures, often near the basolateral surfaces of the cells
and possibly associated with the basolateral membranes.
In no tissue was the protein observed in nuclei.
Claudin 7 localization in mammary tumors
We examined four types of mammary tumor: tumors arising
in the transgenic mouse expressing the Erb2 receptor
under the control of the mammary tumor virus promoter [9],
and three transplantable tumors obtained from the labora-
tory of DM [10]. All tumors expressed claudin 7 mRNA at
levels no more than twice that in the lactating mammary
gland when normalized to ribosomal RNA (Fig. 4a).
Although tumors themselves are more closely related to the
pregnant gland, we chose the lactating gland for compari-
son because, like the tumors, it is composed largely of epi-
thelial cells. Interestingly, the ratio of claudin 7 to keratin 19
in the tumors ranged from 4 to 60 times that in the lactating
gland, reflecting a lower expression of keratin 19, and pos-
sibly a loss of differentiation, in the tumors. In all murine
tumors examined here, claudin 7 was localized to the per-
imembrane region, as illustrated by a section of the TM4
tumor (Fig. 4b). None of these tumors showed ZO1 stain-
ing, indicating that they lacked tight junctions, so that the
claudin 7 observed here was probably associated with
membrane vesicles and possibly with basolateral mem-
branes, as in the normal cells of the mammary gland. Suku-
mar and colleagues [5] observed a loss of claudin 7
expression in some human tumors, particularly lobular
tumors. However, this finding was not true of the mouse
mammary tumors examined.
Discussion
We find claudin 7 to be a constitutive component of the
mammary epithelium, where it is localized to the basolateral
regions of the cell. The finding that the ratio of its mRNA to
that of keratin 19 is relatively constant throughout the
developmental cycle suggests that the molecule might be
an alternative marker to keratin for the proportion of epithe-
lial cells in the mammary gland. It is not clear whether the
more than 1000-fold increase in expression between the
virgin gland and early lactation indicates that the number of
epithelial cells increases in this proportion, because part of
the increase could be a function of an increase in cell size
as the cells differentiate. The rapid increase between the
virgin gland and pregnancy day 5 is consistent with studies
showing a peak of thymidine incorporation between days 2
and 5 of pregnancy, when about 25% of the cells were
labeled [14,15]. In both studies, labeling decreased there-
after but remained about 10% almost to the end of
pregnancy, consistent with the continued increase in both
claudin 7 and keratin mRNA up to day P18.
Our findings are consistent with images of claudin staining
in the human mammary gland, where a diffuse diaminoben-
zidene stain from alkaline phosphatase localization was
present throughout the cytoplasm [5]. However, in that
study no attempt was made to localize claudin 7 stain with
tight-junction components. Basolateral localization of other
claudins has been observed. Claudin 1 was localized to the
Figure 4
Claudin 7 in mouse mammary tumors Claudin 7 in mouse mammary tumors. (a) Black bars, mRNA levels by 
real-time reverse transcriptase polymerase chain reaction in the four 
murine mammary tumors and the lactating gland, chosen for compari-
son because it, like the tumors, contains a large proportion of epithelial 
cells. All values are normalized to ribosomal RNA. Gray bars, Ratio of 
claudin 7 mRNA to keratin 19 mRNA. Error bars represent two SEM. 
(b) Claudin 7 distribution in paraffin section of the transplantable tumor 
TM4. The stain is localized to the perimembrane cytoplasm in all cells 
and excluded from nuclei. The arrowheads mark the point in which 
tight-junction stain would be expected if tight junctions were to form; 
however, no ZO1 stain was detected in the section. Scale bar, 20 µm.Available online http://breast-cancer-research.com/content/7/2/R248
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cytoplasm in the epididymis [16], intestine [17], and cornea
[18]. Rahner and colleagues [19] observed claudins 3, 4,
and 5 to be laterally distributed in various portions of the
gastrointestinal track. The finding that claudin 7 is exclu-
sively located in non-tight-junction regions of mammary and
renal epithelial cells [7] suggests that claudins might have
functions other than the regulation of tight-junction perme-
ability. Our images seem to be the first to show claudin 7
stain at sufficiently high resolution to show punctate cyto-
plasmic stain in mammary, airway, and renal epithelial cells.
Even at this resolution, obtained with digital confocal imag-
ing with a resolution of about 200 nm, it is not possible to
discern with certainty whether claudin 7 is inserted into the
convoluted basolateral membranes of these cell types. If
so, it is possible that the cytoplasmic spots represent vesi-
cles en route to and from to the basolateral membranes,
where claudin 7 might interact with components of the
extracellular matrix. As a precedent, claudin 11, an oli-
godendrocyte protein, has been shown to interact with α1-
integrin and to regulate the proliferation and migration of
oligodendrocytes in culture [20]. Other possibilities are
that vesicular claudins could regulate tight-junction
permeability by sequestering tight-junction regulatory mol-
ecules away from tight junctions, or they could be involved
in the stabilization of specialized vesicle compartments
within the cytoplasm. Matsuda and colleagues, using time-
lapse photography, have shown that claudin-containing
cytoplasmic vesicles can originate from the tight junctions
as the epithelial layer remodels [13]. However, because
claudin 7 is never observed in association with tight junc-
tions in mammary epithelial cells, it seems unlikely that
these vesicles have an origin in the junctional complex. Our
mammary epithelial cell model, EPH4 cells, does possess
a complement of cytoplasmic vesicles that could allow live-
cell imaging studies to determine the origin and disposition
of claudin 7-containing vesicles. It is likely that the function
of the vesicles can be better assessed after analysis of the
composition of the claudin 7-containing cytoplasmic
vesicles.
Claudin 7 expression was inversely correlated with histo-
logical grade in a large series of breast tumors [5]. These
same authors found, similarly to our observations with
EPH4 cells, that claudin 7 colocalized with ZO1 in MCF7
breast cancer cells and could also be observed in cytoplas-
mic spots. It was present in luminal cells of the human
breast, where the diaminobenzidine staining seemed to be
localized to basolateral membranes, although it is difficult
to draw a firm conclusion in the absence of an apical
marker like ZO1. An image of ductal carcinoma in situ in
that paper shows a distribution of stain remarkably similar
to that of the TM10 tumor shown in Fig. 4b. This tumor line
has been shown to have a ductal morphology [10].
Thus, we conclude that low-grade breast carcinomas show
a cellular distribution of stain similar to that observed in the
murine tumors. Interestingly, the murine tumors showed
claudin 7 expression at the mRNA level equal to or higher
than that of the lactating mammary gland, where the largest
proportion of the cells are the luminal epithelial cells that
give rise to mammary tumors. TM4, the most tumorigenic of
these lines, had the highest claudin 7 expression, although
the level was quite variable and not significantly different
from the other lines examined. Interestingly, TM4 and the
MMTV-neu tumor had ratios of claudin 7 to cytokeratin less
than one-eighth of that in the slower-growing TM10 line. All
of the tumors had claudin 7 to cytokeratin ratios signifi-
cantly higher than those in the pregnant or lactating mam-
mary gland. These observations suggest that loss of the
cytoplasmic architectural stability conferred by keratin
might be an early event in tumorigenesis. Together with the
data from the Sukumar laboratory [5], we might speculate
that loss of claudin 7, as occurs in high-grade tumors, alters
cell–matrix interactions, allowing a greater degree of cell
mobility and contributing to metastasis.
Conclusion
Claudin 7 is a constitutive component of mammary epithe-
lium at all stages of development, maintaining a level of
gene expression that is approximately proportional to the
amount of epithelial tissue in the gland. The protein is not
associated with tight junctions but is found in particulate
structures in the cytoplasm, generally denser at basolateral
borders of the cells. Its distribution is similar in mammary
tumors, at least in more well-differentiated ones. Claudin 7
function in the mammary epithelium is currently unknown
but might be related to vesicle trafficking or cell-matrix
interactions.
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